VIEW2 Study: VEGF-Trap and neovascular AMD (link: http://www.clinicaltrials.gov/ct2/show/NCT00637377?term=View+2&rank=1 )
GATE-Study: Preventing progression of geographic atrophy (link: http://www.clinicaltrials.gov/ct2/show/study/NCT00890097?term=GATE&rank=4 )
GALILEO-Study: VEGF-Trap and central retinal vein occlusion (link: http://www.clinicaltrials.gov/ct2/show/study/NCT00943072?term=crvo&rank=5&show_locs=Y#locn )
MIZAR-Study: Preventing diabetic macula edema after cataract extraction (link: http://www.clinicaltrials.gov/ct2/show/NCT00782717?term=diabetic+AND+edema+AND+alcon&rank=1 )
PASCAL-Study: New laser method and diabetic retinopathy (link: http://www.clinicaltrials.gov/ct2/show/NCT00682240?term=PASCAL+diabetic+retinopathy&rank=3 )
MANTA-Study: Comparing Lucentis® and Avastin® (link: http://www.clinicaltrials.gov/ct2/show/NCT00710229?term=MANTA&rank=1 )
WALTZ-Studie: AL-39324 bei exudativer AMD (link: http://www.clinicaltrials.gov/ct2/show/NCT00992563?term=WALTZ&rank=1)
ERG-Study: Electrophysiologic examination and follow-up of different macula diseases.
Lucentis-Study: Observing the functional and anatomical development in patients with neovascular AMD and monthly Lucentis® injections.
Triamcinolon-Study: Observing the functional and anatomical development of Triamcinolon therapy in patients with uveitic macula edema.